Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years
Bibliographic record
Abstract
Introduction:The impact of race on outcomes of allogeneic hematopoietic cell transplants (HCT) has long been a field of research.The Center for International Blood and Marrow Transplant Research (CIBMTR) studies have shown worse survival for Black and Hispanic patients within the first year after HCT, but rates evened out for one-year survivors.From our personal experience, we hypothesize that the outcomes of South Asians (age ≥ 45 years) receiving myeloablative conditioning (MAC) are also worse compared to other races.Methods: This is a retrospective single-centre study.All patients (age ≥ 45 years) undergoing MAC-HCT for hematological malignancies from 2011-2022 were included.The primary outcome was overall survival (OS).Secondary outcomes were non-relapse mortality (NRM), incidence of grade 2-4 acute graft versus host disease (GVHD), moderate-severe chronic GVHD and relapse incidence (RI).The survival analysis was performed using Kaplan-Meier analysis and log-rank test.The GVHD, NRM and RI rates were calculated using the cumulative incidence (CI) of competing events and the Gray test.EZR was used for statistical analysis.Results: Of the 483 patients included, there were 28 (5.8%)South Asians (SA), 73 (15.1%), other Asians (East Asians (EA)/Southeast Asians (SEA), and 382 (79.1%)Whites (W).Asians were less likely to get matched unrelated donor-HCT than Whites (SA 21%, EA/SEA 30%, W 45%, p=0.009).The three groups were comparable regarding the recipient and donor sex and performance status.The proportion of SA with HCT-CI ≥ 3 was significantly higher (SA 50%, EA/SEA 37%, W 31%, p=0.03).SA patients were more likely to be obese (body mass index ≥ 30 kg/m 2 ) (SA 29%, EA/SEA 5%, W 19%, p=0.005).There were fewer cytomegalovirus (CMV) serological mismatches among the Asians (SA 25%, EA/SEA 26%, W 43%, p=0.009).There was no difference in the conditioning type and CD34 cell dose.However, fewer Asians received Antithymocyte globulin/post-transplant cyclophosphamide as GVHD prophylaxis (SA 39%, EA/SEA 42%, W 45%, p=0.0009).The median OS was significantly shorter in SA (SA 19, EA/SEA 103, W 65 months, p=0.04).The 2-year NRM was significantly higher in SA (SA 35.7%, EA/SEA 13.7%, W 16%, p=0.03).The CI of grade 2-4 acute and moderate-severe chronic GVHD was not significantly different (p=0.7 & 0.6).The 2-year RI was also not significantly different (SA 28.5%, EA/SEA 24.7%, W 28%, p=0.8).Conclusion: Our study confirms that South Asians aged ≥ 45 years have worse survival after MAC-HCT.Supportive care is unable to overcome the differences in the outcomes.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".